SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Relmada Therapeutics, Inc. – ‘10-K’ for 12/31/22 – ‘XML’

On:  Thursday, 3/23/23, at 4:49pm ET   ·   For:  12/31/22   ·   Accession #:  1213900-23-22463   ·   File #:  1-39082

Previous ‘10-K’:  ‘10-K’ on 3/25/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 3/19/24 for 12/31/23   ·   30 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/23/23  Relmada Therapeutics, Inc.        10-K       12/31/22   55:4.4M                                   EdgarAgents LLC/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    952K 
 2: EX-23.1     Consent of Marcum LLP                               HTML     15K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     16K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     16K 
12: R1          Document And Entity Information                     HTML     85K 
13: R2          Consolidated Balance Sheets                         HTML     95K 
14: R3          Consolidated Balance Sheets (Parentheticals)        HTML     36K 
15: R4          Consolidated Statements of Operations               HTML     59K 
16: R5          Consolidated Statements of Operations               HTML     25K 
                (Parentheticals)                                                 
17: R6          Consolidated Statements of Changes in               HTML     77K 
                Stockholders? Equity                                             
18: R7          Condensed Consolidated Statements of Cash Flows     HTML     92K 
19: R8          Business                                            HTML     19K 
20: R9          Summary of Significant Accounting Policies          HTML     45K 
21: R10         Prepaid Expenses                                    HTML     21K 
22: R11         Accrued Expenses                                    HTML     21K 
23: R12         Stockholders' Equity                                HTML     65K 
24: R13         Income Taxes                                        HTML     34K 
25: R14         Commitments and Contingencies                       HTML     30K 
26: R15         Related Party Transactions                          HTML     21K 
27: R16         Other Postretirement Benefit Plan                   HTML     22K 
28: R17         Subsequent Events                                   HTML     19K 
29: R18         Accounting Policies, by Policy (Policies)           HTML     83K 
30: R19         Summary of Significant Accounting Policies          HTML     21K 
                (Tables)                                                         
31: R20         Prepaid Expenses (Tables)                           HTML     21K 
32: R21         Accrued Expenses (Tables)                           HTML     21K 
33: R22         Stockholders' Equity (Tables)                       HTML     45K 
34: R23         Income Taxes (Tables)                               HTML     29K 
35: R24         Summary of Significant Accounting Policies          HTML     46K 
                (Details)                                                        
36: R25         Summary of Significant Accounting Policies          HTML     23K 
                (Details) - Schedule of anti-dilutive securities                 
37: R26         Prepaid Expenses (Details) - Schedule of prepaid    HTML     27K 
                expenses                                                         
38: R27         Accrued Expenses (Details) - Schedule of accrued    HTML     29K 
                expenses                                                         
39: R28         Stockholders' Equity (Details)                      HTML    349K 
40: R29         Stockholders' Equity (Details) - Schedule of        HTML     65K 
                changes in options                                               
41: R30         Stockholders' Equity (Details) - Schedule of        HTML     35K 
                unrecognized stock-based compensation expense                    
42: R31         Stockholders' Equity (Details) - Schedule of the    HTML     33K 
                changes in outstanding warrants                                  
43: R32         Stockholders' Equity (Details) - Schedule of        HTML     23K 
                stock-based compensation expense                                 
44: R33         Income Taxes (Details)                              HTML     25K 
45: R34         Income Taxes (Details) - Schedule of deferred tax   HTML     39K 
                assets                                                           
46: R35         Income Taxes (Details) - Schedule of reconcilation  HTML     34K 
                of the statutory tax rate to the effective tax                   
                rate                                                             
47: R36         Commitments and Contingencies (Details)             HTML     60K 
48: R37         Related Party Transactions (Details)                HTML     30K 
49: R38         Other Postretirement Benefit Plan (Details)         HTML     20K 
50: R39         Subsequent Events (Details)                         HTML     33K 
53: XML         IDEA XML File -- Filing Summary                      XML     93K 
51: XML         XBRL Instance -- f10k2022_relmadatherap_htm          XML    686K 
52: EXCEL       IDEA Workbook of Financial Reports                  XLSX    116K 
 8: EX-101.CAL  XBRL Calculations -- rlmd-20221231_cal               XML     73K 
 9: EX-101.DEF  XBRL Definitions -- rlmd-20221231_def                XML    532K 
10: EX-101.LAB  XBRL Labels -- rlmd-20221231_lab                     XML   1.11M 
11: EX-101.PRE  XBRL Presentations -- rlmd-20221231_pre              XML    534K 
 7: EX-101.SCH  XBRL Schema -- rlmd-20221231                         XSD    142K 
54: JSON        XBRL Instance as JSON Data -- MetaLinks              284±   423K 
55: ZIP         XBRL Zipped Folder -- 0001213900-23-022463-xbrl      Zip    280K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.23.1 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 143 </ContextCount>
<ElementCount> 295 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 31 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 4 </UnitCount>
<MyReports>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 000 - Document - Document And Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/DocumentAndEntityInformation </Role>
<ShortName> Document And Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 001 - Statement - Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ConsolidatedBalanceSheet </Role>
<ShortName> Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 002 - Statement - Consolidated Balance Sheets (Parentheticals) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals </Role>
<ShortName> Consolidated Balance Sheets (Parentheticals) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 003 - Statement - Consolidated Statements of Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ConsolidatedIncomeStatement </Role>
<ShortName> Consolidated Statements of Operations </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 004 - Statement - Consolidated Statements of Operations (Parentheticals) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ConsolidatedIncomeStatement_Parentheticals </Role>
<ShortName> Consolidated Statements of Operations (Parentheticals) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 005 - Statement - Consolidated Statements of Changes in Stockholders??? Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ShareholdersEquityType2or3 </Role>
<ShortName> Consolidated Statements of Changes in Stockholders??? Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 006 - Statement - Condensed Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ConsolidatedCashFlow </Role>
<ShortName> Condensed Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 007 - Disclosure - Business </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/Business </Role>
<ShortName> Business </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 008 - Disclosure - Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/SummaryofSignificantAccountingPolicies </Role>
<ShortName> Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 009 - Disclosure - Prepaid Expenses </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/PrepaidExpenses </Role>
<ShortName> Prepaid Expenses </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 010 - Disclosure - Accrued Expenses </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/AccruedExpenses </Role>
<ShortName> Accrued Expenses </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 011 - Disclosure - Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/StockholdersEquity </Role>
<ShortName> Stockholders' Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 012 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/IncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 013 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/CommitmentsandContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 014 - Disclosure - Related Party Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/RelatedPartyTransactions </Role>
<ShortName> Related Party Transactions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 015 - Disclosure - Other Postretirement Benefit Plan </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/OtherPostretirementBenefitPlan </Role>
<ShortName> Other Postretirement Benefit Plan </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 016 - Disclosure - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/SubsequentEvents </Role>
<ShortName> Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 017 - Disclosure - Accounting Policies, by Policy (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/AccountingPoliciesByPolicy </Role>
<ShortName> Accounting Policies, by Policy (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://relmada.com/role/SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 18 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 018 - Disclosure - Summary of Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/SummaryofSignificantAccountingPoliciesTables </Role>
<ShortName> Summary of Significant Accounting Policies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://relmada.com/role/SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 19 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 019 - Disclosure - Prepaid Expenses (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/PrepaidExpensesTables </Role>
<ShortName> Prepaid Expenses (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://relmada.com/role/PrepaidExpenses </ParentRole>
<Position> 20 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 020 - Disclosure - Accrued Expenses (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/AccruedExpensesTables </Role>
<ShortName> Accrued Expenses (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://relmada.com/role/AccruedExpenses </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 021 - Disclosure - Stockholders' Equity (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/StockholdersEquityTables </Role>
<ShortName> Stockholders' Equity (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://relmada.com/role/StockholdersEquity </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 022 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/IncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://relmada.com/role/IncomeTaxes </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 023 - Disclosure - Summary of Significant Accounting Policies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails </Role>
<ShortName> Summary of Significant Accounting Policies (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/SummaryofSignificantAccountingPoliciesTables </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 024 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of anti-dilutive securities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ScheduleofantidilutivesecuritiesTable </Role>
<ShortName> Summary of Significant Accounting Policies (Details) - Schedule of anti-dilutive securities </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/SummaryofSignificantAccountingPoliciesTables </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 025 - Disclosure - Prepaid Expenses (Details) - Schedule of prepaid expenses </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ScheduleofprepaidexpensesTable </Role>
<ShortName> Prepaid Expenses (Details) - Schedule of prepaid expenses </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/PrepaidExpensesTables </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 026 - Disclosure - Accrued Expenses (Details) - Schedule of accrued expenses </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ScheduleofaccruedexpensesTable </Role>
<ShortName> Accrued Expenses (Details) - Schedule of accrued expenses </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/AccruedExpensesTables </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 027 - Disclosure - Stockholders' Equity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/StockholdersEquityDetails </Role>
<ShortName> Stockholders' Equity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/StockholdersEquityTables </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 028 - Disclosure - Stockholders' Equity (Details) - Schedule of changes in options </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ScheduleofchangesinoptionsTable </Role>
<ShortName> Stockholders' Equity (Details) - Schedule of changes in options </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/StockholdersEquityTables </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 029 - Disclosure - Stockholders' Equity (Details) - Schedule of unrecognized stock-based compensation expense </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable </Role>
<ShortName> Stockholders' Equity (Details) - Schedule of unrecognized stock-based compensation expense </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/StockholdersEquityTables </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 030 - Disclosure - Stockholders' Equity (Details) - Schedule of the changes in outstanding warrants </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ScheduleofthechangesinoutstandingwarrantsTable </Role>
<ShortName> Stockholders' Equity (Details) - Schedule of the changes in outstanding warrants </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/StockholdersEquityTables </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 031 - Disclosure - Stockholders' Equity (Details) - Schedule of stock-based compensation expense </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ScheduleofstockbasedcompensationexpenseTable </Role>
<ShortName> Stockholders' Equity (Details) - Schedule of stock-based compensation expense </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/StockholdersEquityTables </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 032 - Disclosure - Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/IncomeTaxesDetails </Role>
<ShortName> Income Taxes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/IncomeTaxesTables </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 033 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ScheduleofdeferredtaxassetsTable </Role>
<ShortName> Income Taxes (Details) - Schedule of deferred tax assets </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/IncomeTaxesTables </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 034 - Disclosure - Income Taxes (Details) - Schedule of reconcilation of the statutory tax rate to the effective tax rate </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/ScheduleofreconcilationofthestatutorytaxratetotheeffectivetaxrateTable </Role>
<ShortName> Income Taxes (Details) - Schedule of reconcilation of the statutory tax rate to the effective tax rate </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/IncomeTaxesTables </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 035 - Disclosure - Commitments and Contingencies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/CommitmentsandContingenciesDetails </Role>
<ShortName> Commitments and Contingencies (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/CommitmentsandContingencies </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 036 - Disclosure - Related Party Transactions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/RelatedPartyTransactionsDetails </Role>
<ShortName> Related Party Transactions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/RelatedPartyTransactions </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 037 - Disclosure - Other Postretirement Benefit Plan (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/OtherPostretirementBenefitPlanDetails </Role>
<ShortName> Other Postretirement Benefit Plan (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/OtherPostretirementBenefitPlan </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="f10k2022_relmadatherap.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 038 - Disclosure - Subsequent Events (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://relmada.com/role/SubsequentEventsDetails </Role>
<ShortName> Subsequent Events (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://relmada.com/role/SubsequentEvents </ParentRole>
<Position> 39 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<Logs>
<Log type="Warning"> [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:EarningsPerShareDiluted, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - f10k2022_relmadatherap.htm 8274, 8275, 8276, 8277 </Log>
</Logs>
<InputFiles>
<File doctype="10-K" original="f10k2022_relmadatherap.htm"> f10k2022_relmadatherap.htm </File>
<File> f10k2022ex23-1_relmadatherap.htm </File>
<File> f10k2022ex31-1_relmadatherap.htm </File>
<File> f10k2022ex31-2_relmadatherap.htm </File>
<File> f10k2022ex32-1_relmadatherap.htm </File>
<File> f10k2022ex32-2_relmadatherap.htm </File>
<File> rlmd-20221231.xsd </File>
<File> rlmd-20221231_cal.xml </File>
<File> rlmd-20221231_def.xml </File>
<File> rlmd-20221231_lab.xml </File>
<File> rlmd-20221231_pre.xml </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy items="498"> http://fasb.org/us-gaap/2022 </BaseTaxonomy>
<BaseTaxonomy items="37"> http://xbrl.sec.gov/dei/2022 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/21/23  Relmada Therapeutics, Inc.        S-8         6/21/23    4:202K                                   EdgarAgents LLC/FA

29 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/17/23  Relmada Therapeutics, Inc.        8-K:1,5,9   1/12/23   12:289K                                   EdgarAgents LLC/FA
 1/05/23  Relmada Therapeutics, Inc.        8-K:1,8,9   1/01/23   11:248K                                   EdgarAgents LLC/FA
12/28/22  Relmada Therapeutics, Inc.        8-K:1,9    12/27/22   11:209K                                   EdgarAgents LLC/FA
 9/22/22  Relmada Therapeutics, Inc.        8-K:1,3,5,9 9/21/22   13:939K                                   EdgarAgents LLC/FA
 8/10/21  Relmada Therapeutics, Inc.        10-Q        6/30/21   54:3.4M                                   EdgarAgents LLC/FA
 3/24/21  Relmada Therapeutics, Inc.        10-K       12/31/20   65:4.7M                                   EdgarAgents LLC/FA
 8/12/20  Relmada Therapeutics, Inc.        S-3                    3:499K                                   EdgarAgents LLC/FA
 5/15/20  Relmada Therapeutics, Inc.        10-Q        3/31/20   54:2.7M                                   EdgarAgents LLC/FA
 3/09/20  Relmada Therapeutics, Inc.        8-K:1,5,9   3/06/20    2:33K                                    EdgarAgents LLC/FA
 1/10/20  Relmada Therapeutics, Inc.        8-K:1,5,9   1/09/20    4:294K                                   EdgarAgents LLC/FA
12/26/19  Relmada Therapeutics, Inc.        8-K:5,8,9  12/19/19    6:200K                                   EdgarAgents LLC/FA
12/03/19  Relmada Therapeutics, Inc.        8-K:1,8,9  11/27/19    6:7.7M                                   EdgarAgents LLC/FA
11/13/19  Relmada Therapeutics, Inc.        10-Q        9/30/19   56:2.7M                                   EdgarAgents LLC/FA
 9/27/19  Relmada Therapeutics, Inc.        8-K:3,5,9   9/26/19    3:254K                                   EdgarAgents LLC/FA
 5/15/19  Relmada Therapeutics, Inc.        10-Q        3/31/19   66:5M                                     EdgarAgents LLC/FA
11/13/18  Relmada Therapeutics, Inc.        10-Q        9/30/18   61:3.2M                                   EdgarAgents LLC/FA
 5/14/18  Relmada Therapeutics, Inc.        10-Q        3/31/18   62:3M                                     EdgarAgents LLC/FA
 2/12/18  Relmada Therapeutics, Inc.        10-Q       12/31/17   62:2.9M                                   EdgarAgents LLC/FA
 1/19/18  Relmada Therapeutics, Inc.        8-K:1,9     1/16/18    4:247K                                   EdgarAgents LLC/FA
11/25/15  Relmada Therapeutics, Inc.        8-K:5,9    11/20/15    2:151K                                   EdgarAgents LLC/FA
 8/07/15  Relmada Therapeutics, Inc.        8-K:1,5,9   8/03/15    8:532K                                   EdgarAgents LLC/FA
 7/16/15  Relmada Therapeutics, Inc.        8-K:5,8,9   7/14/15    4:147K                                   EdgarAgents LLC/FA
12/09/14  Relmada Therapeutics, Inc.        S-1/A                 65:10M                                    EdgarAgents LLC/FA
 9/09/14  Relmada Therapeutics, Inc.        10-KT       6/30/14   65:8.3M                                   EdgarAgents LLC/FA
 6/16/14  Relmada Therapeutics, Inc.        8-K:1,3,9   6/10/14    7:916K                                   EdgarAgents LLC/FA
 6/02/14  Relmada Therapeutics, Inc.        8-K:5,9     5/30/14    2:574K                                   EdgarAgents LLC/FA
 5/27/14  Relmada Therapeutics, Inc.        8-K:1,2,3,4 5/20/14   93:13M                                    EdgarAgents LLC/FA
 5/19/14  Relmada Therapeutics, Inc.        8-K:3,9     5/14/14    2:46K                                    Clark Corp Law Group LLP
11/13/12  Relmada Therapeutics, Inc.        S-1        11/09/12    5:644K                                   Clark Corp Law Group LLP
↑Top
Filing Submission 0001213900-23-022463   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 2:25:55.2pm ET